Original Article

You have full text access to this OnlineOpen article

Actinic keratoses†‡

Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial

  1. Vincent D. Criscione AB1,2,
  2. Martin A. Weinstock MD, PhD1,2,3,§,*,
  3. Mark F. Naylor MD4,
  4. Claudia Luque MD1,
  5. Melody J. Eide MD, MPH5,
  6. Stephen F. Bingham PhD6,
  7. for the Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group

Article first published online: 20 APR 2009

DOI: 10.1002/cncr.24284

Issue

Cancer

Cancer

Volume 115, Issue 11, pages 2523–2530, 1 June 2009

Additional Information

How to Cite

Criscione, V. D., Weinstock, M. A., Naylor, M. F., Luque, C., Eide, M. J., Bingham, S. F. and for the Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group (2009), Actinic keratoses. Cancer, 115: 2523–2530. doi: 10.1002/cncr.24284

Author Information

  1. 1

    Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, Rhode Island

  2. 2

    Departments of Dermatology and Community Health, Brown University, Providence, Rhode Island

  3. 3

    Department of Dermatology, Rhode Island Hospital, Providence, Rhode Island

  4. 4

    Department of Dermatology, Veterans Affairs Medical Center, Oklahoma City, Oklahoma

  5. 5

    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan

  6. 6

    Veterans Affairs Cooperative Studies Coordinating Center, Perry Point, Maryland

  1. §

    Fax: (401) 457-3332

*Dermatoepidemiology Unit-111D, VA Medical Center, 830 Chalkstone Avenue, Providence, RI 02908-4799

  1. †

    Key personnel of the Department of Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial include the following: Study Chairman's Office: Martin A. Weinstock (Chair) and Kimberly Marcolivio (Providence, RI). Executive Committee: Martin Weinstock (Providence, RI), Stephen Bingham (Perry Point, Md), John DiGiovanna (Providence, RI), Russell Hall (Durham, NC), Mark Naylor (Oklahoma City, Okla), J. Richard Taylor (Miami, Fla), Julia Vertrees (Albuquerque, NM), and Clifton White (Portland, Ore). Clinical Centers: Durham, NC (Russell Hall and Deborah Hannah); Chicago, Ill (Hines) (David Eilers, Tehming Liang, Nadia Sakla, and Ann Kreuger); Long Beach, Calif (Gary Cole, Edward Jeffes, and Terri Labrador); Miami, Fla (J. Richard Taylor, Robert Kirsner, Jonette E. Kerri, Anna G. Falabela, and Margarita Givens); Oklahoma City, Okla (Mark Naylor, Mary Beth Benson, and Lisa Perry); and Phoenix, Ariz (James Kalivas, Catherine Yanni, Selma Targovnik, Janet Austin, and Susan Collier). Cooperative Studies Program Coordinating Center (Perry Point, Md): Joseph F. Collins, Stephen Bingham, Beverly Calvert, Philip Connor, Colleen Crigler, Dawn Davis, Pat Grubb, Judy Kelly, Gail Kirk, Karen Lawson, Linda Linzy, Lorrine Palmer, and Maxine Rhoads. Cooperative Studies Program Clinical Research Pharmacy Coordinating Center (Albuquerque, NM): Mike Sather, Erica Copeland, Carol Fye, William Gagne, Patricia Grimes de Naranjo, Chad Messick, and Julia Vertrees. Dermatopathologists: Michael Piepkorn (Bellevue, Wash) and Clifton White (Portland, Ore). Data and Safety Monitoring Board: Robert Lew (Boston, Mass), Irwin Braverman (New Haven, Conn), Bernard Cole (Lebanon, NH), Richard Kalish (Stony Brook, NY), David McLean (Vancouver, BC, Canada), and Bruce Thiers (Charleston, SC).

  2. ‡

    This article is US Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 20 MAY 2009
  2. Article first published online: 20 APR 2009
  3. Manuscript Accepted: 20 NOV 2008
  4. Manuscript Revised: 14 NOV 2008
  5. Manuscript Received: 25 SEP 2008

Funded by

  • Cooperative Studies Program (CSP) Grant 402 from the US Department of Veterans Affairs Office of Research and Development
  • Summer Research Assistantship Grant from the Alpert Medical School of Brown University
  • Brown University Department of Dermatology
  • National Institutes of Health. Grant Numbers: R01CA106592, R01CA106807, R25CA087972, R01AR49342

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (196K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Waqas R. Shaikh, Alan Geller, Gwen Alexander, Maryam M. Asgari, Gunther J. Chanange, Stephen Dusza, Melody J. Eide, Suzanne W. Fletcher, Jacqueline M. Goulart, Allan C. Halpern, Shoshana Landow, Ashfaq A. Marghoob, Elizabeth A. Quigley, Martin A. Weinstock, Developing an Interactive Web-Based Learning Program on Skin Cancer: the Learning Experiences of Clinical Educators, Journal of Cancer Education, 2012,

    CrossRef

  2. 2
    Dan F Spandau, Davina A Lewis, Ally-Khan Somani, Jeffrey B Travers, Fractionated Laser Resurfacing Corrects the Inappropriate UVB Response in Geriatric Skin, Journal of Investigative Dermatology, 2012, 132, 6, 1591

    CrossRef

  3. 3
    Vladimir Ratushny, Michael D. Gober, Ryan Hick, Todd W. Ridky, John T. Seykora, From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma, Journal of Clinical Investigation, 2012, 122, 2, 464

    CrossRef

  4. 4
    Devita Surjana, Gary M Halliday, Andrew J Martin, Fergal J Moloney, Diona L Damian, Oral Nicotinamide Reduces Actinic Keratoses in Phase II Double-Blinded Randomized Controlled Trials, Journal of Investigative Dermatology, 2012, 132, 5, 1497

    CrossRef

  5. 5
    Jason Hadley, Payam Tristani-Firouzi, Christopher Hull, Scott Florell, Murray Cotter, Michael Hadley, Results of an Investigator-Initiated Single-Blind Split-Face Comparison of Photodynamic Therapy and 5% Imiquimod Cream for the Treatment of Actinic Keratoses, Dermatologic Surgery, 2012, 38, 5
    Direct Link:
  6. 6
    Simon A. Ritchie, Manisha J. Patel, Stanley J. Miller, Therapeutic Options to Decrease Actinic Keratosis and Squamous Cell Carcinoma Incidence and Progression in Solid Organ Transplant Recipients: A Practical Approach, Dermatologic Surgery, 2012, 38, 6
    Direct Link:
  7. 7
    Martin A Weinstock, Stephen F Bingham, John J DiGiovanna, Amilcar E Rizzo, Kim Marcolivio, Russell Hall, David Eilers, Mark Naylor, Robert Kirsner, James Kalivas, Gary Cole, Julia E Vertrees, Tretinoin and the Prevention of Keratinocyte Carcinoma (Basal and Squamous Cell Carcinoma of the Skin): A Veterans Affairs Randomized Chemoprevention Trial, Journal of Investigative Dermatology, 2012, 132, 6, 1583

    CrossRef

  8. 8
    Michael J. Veness, K. Kian Ang, Clinical Radiation Oncology, 2012,

    CrossRef

  9. 9
    P.H. Youl, M. Janda, J.F. Aitken, C.B. Del Mar, D.C. Whiteman, P.D. Baade, Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice, British Journal of Dermatology, 2011, 165, 1
    Direct Link:
  10. 10
    Dai T Tran, Robert Salmon, Field treatment of facial and scalp actinic keratoses with photodynamic therapy: Survey of patient perceptions of treatment satisfaction and outcomes, Australasian Journal of Dermatology, 2011, 52, 3
    Direct Link:
  11. 11
    Valerie R. Yanofsky, Stephen E. Mercer, Robert G. Phelps, Histopathological Variants of Cutaneous Squamous Cell Carcinoma: A Review, Journal of Skin Cancer, 2011, 2011, 1

    CrossRef

  12. 12
    George M. Martin, Impact of interval and combination therapies on the management of actinic keratosis: Review and clinical considerations, Journal of Dermatological Treatment, 2011, 22, 5, 288

    CrossRef

  13. 13
    O. R. Colegio, E. M. Billingsley, Skin Cancer in Transplant Recipients, Out of the Woods. Scientific Retreat of the ITSCC and SCOPE, American Journal of Transplantation, 2011, 11, 8
    Direct Link:
  14. 14
    Marie-France Demierre, Michael Krathen, Cancer of the Skin, 2011,

    CrossRef

  15. 15
    J. Levin, J.Q. Del Rosso, Actinic Keratoses: Natural History and Risk of Malignant Transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial, Yearbook of Dermatology and Dermatologic Surgery, 2010, 2010, 357

    CrossRef

  16. 16
    Benjamin Stoff, Catherine Salisbury, Douglas Parker, Fiona O'Reilly Zwald, Dermatopathology of skin cancer in solid organ transplant recipients, Transplantation Reviews, 2010, 24, 4, 172

    CrossRef

  17. 17
    Diona L. Damian, Photoprotective effects of nicotinamide, Photochemical & Photobiological Sciences, 2010, 9, 4, 578

    CrossRef

  18. 18
    F. Moloney, M. Vestergaard, B. Radojkovic, D. Damian, Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratoses, British Journal of Dermatology, 2010, 162, 5
    Direct Link:
  19. 19
    Jonathan H Zippin, Paul A Chadwick, Lonny R Levin, Jochen Buck, Cynthia M Magro, Soluble Adenylyl Cyclase Defines a Nuclear cAMP Microdomain in Keratinocyte Hyperproliferative Skin Diseases, Journal of Investigative Dermatology, 2010, 130, 5, 1279

    CrossRef

  20. 20
    Editors' Picks, Journal of Investigative Dermatology, 2009, 129, 8, 1847

    CrossRef

View Full Article (HTML) Get PDF (196K)